Page 455 - Read Online
P. 455
Poddar et al. Carcinoma tongue in renal transplant recipient
The incidence of malignancy increases gradually for REFERENCES
ten years after the transplant and becomes as high
as 13.8 fold higher in such patients as compared to 1. Chapman JR, Webster AC. Cancer after renal transplantation: the next
the normal population. The cumulative frequency challenge. Am J Transplant 2004;4:841-2.
increases with increase in duration of follow-up. 2. Malleshappa P, Aghariya M, Tampi C, Shah BV. Squamous cell
This patient developed his cancer 18 years after carcinoma of tongue in a renal transplant recipient. Indian J Med
[9]
transplant. Other risk factors attributable to Paediatr Oncol 2009;30:136-7.
development of malignancy in these patients is 3. Lee YW, Gisser SD. Squamous cell carcinoma of the tongue in a
advancing age, viral infections, cigarette smoking, and nine year renal transplant survivor: a case report with a discussion of
[10]
transmission of malignancy from donor cells. Thus, the risk of development of epithelial carcinomas in renal transplant
strict follow-up and vigilance for signs and symptoms survivors. Cancer 1978;41:1-6.
of malignancy should be followed in patients with 4. Rama I, Grinyó JM. Malignancy after renal transplantation: the role of
organ transplantation on immunosuppressive drugs, immunosuppression. Nat Rev Nephrol 2010;6:511-9.
even after decades of transplant. 5. Sheil AG. Cancer report 2001. In: Ross GR, editor. ANZDATA
Financial support and sponsorship Registry Report 2001. Adelaide, South Australia: Australia and New
Nil. Zealand Dialysis and Transplant Registry; 2001. p. 84-90.
6. Tsai MC, Chen YT, Chien YS, Chen TC, Hu TH. Hepatitis B
Conflicts of interest virus infection and renal transplantation. World J Gastroenterol
There are no conflicts of interest. 2010;16:3878-87.
7. Silveira FP, Husain S. Fungal infections in solid organ transplantation.
Patient consent Med Mycol 2007;45:305-20.
Patient consent was obtained from the patient. 8. Shoham S, Marr KA. Invasive fungal infections in solid organ
transplant recipients. Future Microbiol 2012;7:639-55.
Ethics approval 9. Yang TC, Shu KH, Cheng CH, Wu MJ, Lian JD. Malignancy following
Ethics approval was obtained from the institutional renal transplantation. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61:281-8.
ethical committee for preparation and publication of 10. Danpanich E, Kasiske BL. Risk factors for cancer in renal transplant
this paper. recipients. Transplantation 1999;68:1859-64.
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ November 25, 2016 445